Insider buyingNow I'm no conspiracy theorist, but damned if I'm not wondering if there's some sort of coincidence between the stubbornly low stock price and ...
https://www.tipranks.com/experts/insiders/patrick-d.-kirwin#google_vignette
Patrick D. Kirwin, Director at ProMIS Neurosciences, holds 99.10K shares in ProMIS Neurosciences (Ticker: PMN). Most recently, Patrick D. Kirwin Bought $10,000 shares of ProMIS Neurosciences on Aug 15, 2024 for an estimated value of 12.40K https://ph.investing.com/news/stock-market-news/promis-neurosciences-director-shafmaster-purchases-255750-in-stock-93CH-1452221
In a recent series of transactions, Madge K. Shafmaster, a director at ProMIS Neurosciences Inc. (OTC:PMN), made significant purchases of company stock, totaling $255,750. These acquisitions were made over three separate days, with prices ranging from $1.2511 to $1.3004 per share.
On September 20, 2024, Shafmaster bought 60,000 shares at $1.2511 each. This was followed by a purchase of 70,000 shares at $1.2808 per share on September 23, and another 70,000 shares at $1.3004 each on September 24. The transactions collectively increased Shafmaster's holdings to 208,333 common shares in the pharmaceutical preparations company.
These stock purchases by a member of ProMIS Neurosciences' board indicate a bolstering of Shafmaster's investment in the company, as reflected by the public filing. For investors, such insider transactions can offer insights into the confidence that company executives and directors have in the firm's future prospects.